Health
Danaher’s decision to spin off its water business is a win-win for long-term investors
The medical diagnostics and health tech firm has a great track record for creating shareholder value through organic investments and mergers and divestitures. Source
Read More
Here’s how we’re positioned in four sectors and some of the stocks we like in each
CNBC’s Jim Cramer gave investors advice on how to build a strong portfolio during the Federal Reserve’s struggle to reduce inflation. Source
Read More
U.S. monkeypox outbreak is slowing, CDC official says
Monkeypox continues to spread across the U.S., but the pace of new cases has slowed over the last several weeks, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, told lawmakers Wednesday. While the virus is still spreading at a rapid clip in certain regions of the U.S., the growth of new […]
Read More
At least 17 million people in Europe suffered long Covid in first 2 years of pandemic, WHO report says
New research suggests at least 17 million people across Europe and central Asia suffered from long Covid within the first two years of the pandemic. Filadendron | E+ | Getty Images At least 17 million people in Europe suffered from “long Covid” within the first two years of the coronavirus pandemic, according to a new […]
Read More
How Big Tech is muscling in on health care — we rank the strategies of our 4 core holdings
They’re all vying for a slice of the more than $4 trillion that Americans spend each year on their health. Source
Read More
Los Angeles health officials are investigating the death of a person who had monkeypox
A health care worker administers a dose of the JYNNEOS Monkeypox vaccine at a pop-up vaccination clinic in Los Angeles, California, on August 9, 2022. Patrick T. Fallon | AFP | Getty Images Los Angeles health officials are investigating the death of a person who had monkeypox. Dr. Rita Singhal, director of disease control in […]
Read More
Morgan Stanley calls for a 26% gain in this under-the-radar ‘safe port in the storm’
Morgan Stanley says investors looking for a hideout in this volatile market should consider putting their money in this lesser known biotechnology stock. Analyst Andrew Galler initiated coverage of Halozyme Therapeutics with an overweight rating and a $50 price target, calling the company a “safe port in a storm.” “Given the macro backdrop, we view […]
Read More
Buy this niche health care tech leader as pharmacies shift toward automation, Bank of America says
It’s a good time for investors to stock up on shares of Omnicell as the pharmacy industry turns toward automation, Bank of America says. Analyst Allen Lutz initiated coverage of the provider of automated solutions for medication management with a buy rating and $120 price target, saying in a note to clients Friday that he sees […]
Read More
2 takeaways from the Investing Club’s ‘Morning Meeting’ on Thursday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We made two trades: AMD, CVX Quick mentions: AAPL, QCOM, HUM 1. Two trades: AMD, CVX Stocks turned mixed Thursday after originally dropping during Federal Reserve Chairman Jerome Powell’s morning […]
Read More
HIV-positive people who have monkeypox are hospitalized more often, CDC study says
People living with HIV who have monkeypox are hospitalized more than twice as often as other patients diagnosed with the rapidly spreading virus, according to a study from the Centers for Disease Control and Prevention. In a report published Thursday, the CDC found that 38% of nearly 2,000 people diagnosed with monkeypox between May and […]
Read More